Abbvie, Lda secures contract for Acquisition Of Omalizumab And Paricalcitol For Ulscb

Portugal, March 25 -- Portugal based Abbvie, Lda has secured contract from Unidade Local De Saude De Castelo Branco, Epe for Acquisition Of Omalizumab And Paricalcitol For Ulscb. The value of the contract is worth 759066 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....